Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force…

By D.walaa badawy, L. Burke, C. Gwaltney, N. Leidy, Mona L. Martin, E. Molsen, L. Ring. Value in Health, 2011

1,007 citations recorded by the source corpus.

Subfields: Economics and Econometrics, General Health Professions, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/2801f3b577aef56ce81d82438f7a52a3cf4f85d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Bennett
2. Roxanne E. Jensen
3. E. Basch

Citations in the corpus

• Electronic patient‐reported outcome systems in oncology clinical practice (2012, methodology): “The process is described in full detail by Patrick et al. 5,6 If a clinical practice is selecting an existing questionnaire for use in patient assessment, these criteria should be considered for determining whether the questionnaire was well developed for the intended use.”
• Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016, neutral): “22 Median Brief-POMS (range) 14 (1-50) <.”